Related Experiment Video
Updated: Jul 9, 2025
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.6K
Carvacrol is potential molecule for diabetes treatment
Mustafa Hoca1, Eda Becer2, Hafize Seda Vatansever3,4
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Near East University, Nicosia, Mersin, Turkey.
Archives of Physiology and Biochemistry
|November 29, 2023
Summary
Carvacrol, a compound from plant essential oils, shows significant potential for managing diabetes by improving insulin sensitivity and reducing inflammation. Further research explores its use in combination with existing therapies for better diabetes treatment outcomes.
Area of Science:
- Pharmacology and Toxicology
- Metabolic Diseases
- Natural Product Chemistry
Background:
- Diabetes mellitus is a major global health concern with serious complications.
- Emerging research is exploring natural compounds as alternative diabetes treatments.
- Carvacrol, found in essential oils, presents potential therapeutic benefits for diabetes.
Purpose of the Study:
- To review the anti-diabetic effects of carvacrol.
- To elucidate the mechanisms underlying carvacrol's action in diabetes.
- To assess carvacrol's potential as a standalone or adjunctive therapy for diabetes.
Main Methods:
- Comprehensive literature review of studies on carvacrol and diabetes.
- Analysis of research involving diabetic animal and cell models.
- Examination of carvacrol's impact on diabetes-related biochemical pathways.
Main Results:
- Carvacrol demonstrates anti-diabetic properties through various mechanisms.
- It positively influences diabetes-related enzymes and insulin resistance/sensitivity.
- Carvacrol enhances glucose uptake and exhibits antioxidant and anti-inflammatory effects.
Conclusions:
- Carvacrol shows significant promise as a therapeutic agent for diabetes.
- Its multifaceted mechanisms of action support its potential in diabetes management.
- Carvacrol may be beneficial alone or in combination with conventional anti-diabetic treatments.
More Related Videos
Related Concept Videos
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
182
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
182
01:19Overview of Carbohydrate Metabolism
1.1K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.1K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
209
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
209
01:36Carbohydrate Metabolism
11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
01:24Glucagon-like Receptor Agonists
329
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
329
01:22Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K